Biohaven receives agreement from FDA on initial pediatric study plan

Generics |  News | 0 Comment | 28 Nov, 2017

Biohaven Pharmaceutical Holding Company Ltd. has announced that the Company has received agreement from the U.S. Food and Drug Administration (FDA) on the initial pediatric study plan (iPSP...Read more

Biogen and Alkermes announce license and collaboration agreement

Generics |  News | 0 Comment | 28 Nov, 2017

US based biotech company Biogen and pharma company Alkermes  has announced that they have entered into a global license and collaboration agreement to develop and commercialize ALKS 87...Read more

GSK submits landmark IMPACT data to USFDA for the use of Trelegy Ellipta

Generics |  News | 0 Comment | 27 Nov, 2017

Pharma company, GlaxoSmithKline and Innoviva has announced the filing of a supplemental New Drug Application (sNDA) with the US Food and Drug Administration (FDA) for the use of Trelegy Ell...Read more

Puma biotech and Specialised Therapeutics signs agreement to commercialize NERLYNX®

Generics |  News | 0 Comment | 24 Nov, 2017

Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Australia, New Zealand and South East Asia Biopha...Read more

Step Pharma completes €14.5 million Series A financing

Generics |  News | 0 Comment | 23 Nov, 2017

France based Step Pharma has announced the closing of a Series A financing totalling €14.5 million. Pontifax will join existing investors led by Kurma Partners, and including Bpifranc...Read more

FDA approves RxSight's light adjustable lens

Generics |  News | 0 Comment | 23 Nov, 2017

Singapore – RxSight (a US based medical devices company) announced that the U.S. Food and Drug Administration (FDA) has approved the RxSight Light Adjustable Lens and the Light Delive...Read more

PeptiDream announces collaboration with Bayer

Generics |  News | 0 Comment | 21 Nov, 2017

Japan based biopharma company PeptiDream Inc. has announced that it has entered into a multi-target discovery collaboration with Germany-based Bayer AG. Under the agreement, PeptiDream wil...Read more

Ionis Pharmaceuticals licenses second antisense GI Drug to Janssen

Generics |  News | 0 Comment | 17 Nov, 2017

U.S. based Pharma Company Ionis Pharmaceuticals, Inc. has announced that it has licensed a second orally delivered Generation 2.5 antisense drug to Janssen Biotech, Inc. (Janssen)...Read more

Cue Biopharma announces research collaboration with Merck

Generics |  News | 0 Comment | 17 Nov, 2017

US based pharma company Cue Biopharma™, Inc. has announced a strategic strategic research collaboration and license agreement with Merck. Under the terms of the deal, the CUE Biologi...Read more

Generic Acticlate tablets launched by Lupin in USA

Generics |  News | 0 Comment | 06 Nov, 2017

Pharma Major Lupin announced the launch of its Doxycycline Hyclate Tablets USP, 75 mg and 150 mg after an approval from the United States Food and Drug Administration (FDA). Lupin’s ...Read more

Lupin net profit falls 31% in Q2 to Rs 455

Generics |  News | 0 Comment | 31 Oct, 2017

Pharma company Lupin reported its financial performance for the second quarter ending September 30th, 2017. The company reported net profit of Rs 662.9 in the same period of previous year....Read more

Lupin receives FDA approval for generic Axiron topical solution

Generics |  News | 0 Comment | 27 Oct, 2017

Pharma Major Lupin has received final approval for its Testosterone Topical Solution, 30 mg per actuation from the United States Food and Drug Administration (FDA) to market a generic versi...Read more

Lupin receives FDA approval for generic Lodosyn tablets and Kapvay Extended-Release tablets

Generics |  News | 0 Comment | 27 Oct, 2017

Pharma Major Lupin has announced that it has received final approval for its Carbidopa Tablets, 25 mg and Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg from the United States Foo...Read more

US FDA approves Bydureon BCise by AstraZeneca for type-2 diabetes

Generics |  News | 0 Comment | 23 Oct, 2017

Biopharma company AstraZeneca has announced its US Food and Drug Administration (FDA) approved Bydureon BCise (exenatide extended-release) injectable suspension. The new for...Read more

NCD: A major public health challenge for Asia-Pacific

Generics |  News | 0 Comment | 11 Oct, 2017

Incidence of non-communicable diseases (NCDs) is on the rise, globally as well as in Asia Pacific region. Implications are far reaching too – while on one hand, it results in a loss o...Read more

Lupin receives FDA approval for generic Corgard Tablets

Generics |  News | 0 Comment | 10 Oct, 2017

Pharma Major Lupin has announced that it has received final approval for its Nadolol Tablets USP, 20 mg, 40 mg, and 80 mg from the United States Food and Drug Administration (FDA) to market...Read more

"Biomarkers can play a key role in improving diagnosis and disease management of heart failure. "

Generics |  Opinion | 0 Comment | 10 Oct, 2017

Singapore - Southeast Asia is home to 9 million heart failure patients. In Singapore alone, it accounts for around 6,000 hospitalizations. Worryingly, not only is heart failure prevalence o...Read more

Arthritis: Act before it gets Late

Generics |  News | 0 Comment | 13 Sep, 2017

Started in 1996, October 12 is recognised as the World Arthritis Day (WAD). Established by Arthritis and Rheumatism International (ARI) and supported by the European League Against Rheumati...Read more